Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of a New Drug Treatment for Acne

ClinicalTrials.gov ID: NCT01326780

Public ClinicalTrials.gov record NCT01326780. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 24, 2026, 10:34 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Double-Blind, Vehicle Controlled, Phase II Study of JNJ 10229570-AAA for the Treatment of Acne Vulgaris

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A study to determine if three different doses of a new acne treatment are safe and better at reducing facial acne than a treatment without active ingredient.

Study identification

NCT ID
NCT01326780
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Bausch Health Americas, Inc.
Industry
Enrollment
431 participants

Conditions and interventions

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 30, 2011
Primary completion
Mar 30, 2012
Completion
Mar 30, 2012
Last update posted
Oct 15, 2019

2011 – 2012

United States locations

U.S. sites
18
U.S. states
13
U.S. cities
17
Facility City State ZIP Site status
University of California, San Diego San Diego California 92093 —
University Clinical Trials, Inc. San Diego California 92123 —
Thomas J. Stephens & Associates, Inc. Colorado Springs Colorado 80915 —
Horizons Clinical Research Ctr., LLC Denver Colorado 80220 —
North Florida Dermatology Jacksonville Florida 32204 —
Hilltop Research St. Petersburg Florida 33710 —
Gwinnett Clinical Research Snellville Georgia 30078 —
Northwestern University Chicago Illinois 60611 —
Dermatology Specialists Research, Inc Louisville Kentucky 40202 —
Minnesota Clinical Study Center Fridley Minnesota 55432 —
TKL Research Rochelle Park New Jersey 07662 —
Academic Dermatology Associates Albuquerque New Mexico 87106 —
Wake Research Associates Raleigh North Carolina 27612 —
Hilltop Research Miamiville Ohio 45147 —
Penn State Medical Center Hershey Pennsylvania 17033 —
Yardley Dermatology Associates Yardley Pennsylvania 19067 —
Research Across America Dallas Texas 75234 —
Reliance Clinical Testing Services Irving Texas 75062 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01326780, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 15, 2019 · Synced Sep 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01326780 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →